pembrolizumab,pemetrexed
merck
['pembro', 'key,note,789', 'pemetrexed', 'sclc', 'lcsm,(-blcsm)', 'nsclc']
pemetrexed and platinum +/-pembrolizumab for tki resistant, egfr-mutant, metastatic nonsquamous
nsclc: phase 3 keynote-789 study. negative trial for pfs and os. small signal for pdl1+? #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm